FDA Adverse Event Malfunction Summary report: N

TRUBALANCE

MDR report key: 5500476 · Received March 15, 2016

Report

Report Number
1052693-2016-00508
Event Type
Malfunction
Date Received
March 15, 2016
Date of Event
February 22, 2016
Report Date
May 31, 2016
Manufacturer
NIPRO DIAGNOSTICS, INC.
Product Code
NBW
PMA / PMN Number
K090495
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION COMPLETED AND PRODUCT EVALUATED WITH NO DEFECT FOUND ON RETURNED METER. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION:STRIP ISSUE, USER IS TESTING WITH EXPIRED TEST STRIPS. CORRECTION OF SERIAL #: METER SERIAL # (B)(4).

Additional Manufacturer Narrative · 1

(MANUFACTURER NARRATIVE = T, CORRECTED DATA = F) (B)(4). INVESTIGATION COMPLETED AND PRODUCT EVALUATED WITH NO DEFECT FOUND ON RETURNED METER. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION:STRIP ISSUE, USER IS TESTING WITH EXPIRED TEST STRIPS.

Description of Event or Problem · 1

CUSTOMER IS COMPLAIN THAT GOT A 'HI' ON HIS METER READING. CUSTOMER STATES THAT FEELS WELL AND REQUIRES NO MEDICAL ATTENTION. THE CUSTOMER'S EXPECTED BLOOD RESULT IS 150-170MG/DL FASTING. VERIFIED THE STRIPS EXPIRED 2/19/2012. REVIEWED METER MEMORY: (B)(6). MEMORY CONCERNS:WITH HI. THE CUSTOMER DID NOT REMEMBER WHEN THE STRIPS WERE OPENED, AND STRIPS EXPIRATION DATE (2/19/2012), STRIPS ARE EXPIRED.

Description of Event or Problem · 1

CUSTOMER IS COMPLAIN THAT GOT A 'HI' ON HIS METER READING. CUSTOMER STATES THAT FEELS WELL AND REQUIRES NO MEDICAL ATTENTION. THE CUSTOMER'S EXPECTED BLOOD RESULT IS 150-170MG/DL FASTING. VERIFIED THE STRIPS EXPIRED 2/19/2012. REVIEWED METER MEMORY (B)(6). MEMORY CONCERNS:WITH HI. THE CUSTOMER DID NOT REMEMBER WHEN THE STRIPS WERE OPENED, AND STRIPS EXPIRATION DATE (2/19/2012), STRIPS ARE EXPIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
157252 TRUBALANCE BLOOD GLUCOSE SYSTEM NBW NIPRO DIAGNOSTICS, INC. TRUBALANCE BL3305

Patients

Seq Age Sex Outcome Treatment
1 0 YR